The latest financial statement is for the quarter ending 2025-09-30.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net (loss) earnings | -938 | -2,832 |
| Depreciation and amortization | 1,703 | 3,306 |
| Amortization of deferred compensation related to stock-based awards | 354 | 858 |
| Deferred income tax expense | 341 | 205 |
| Other non-cash reconciling items | 17 | 383 |
| Trade accounts receivable | -2,528 | -6,865 |
| Inventories | 718 | -203 |
| Prepaid expenses and other current assets | -33 | 438 |
| Other assets | 141 | 36 |
| Operating lease liabilities | -570 | -966 |
| Accounts payable | 388 | -898 |
| Customer deposits and deferred revenue | 934 | 272 |
| Domestic and foreign income taxes payable | -696 | -883 |
| Deferred revenue, net of current portion | -261 | -65 |
| Accrued expenses and other liabilities | 271 | -665 |
| Provision for excess and obsolete inventory | 279 | 304 |
| Net cash provided by operating activities | 3,490 | 4,847 |
| Acquisition of business, net of cash acquired | 0 | 0 |
| Purchases of property and equipment | 407 | 691 |
| Net cash used in investing activities | -407 | -691 |
| Repayments of short-term borrowings, net of proceeds | 239 | 3,613 |
| Repayments of long-term debt | 1,025 | 2,050 |
| Repurchases of common stock | 0 | - |
| Proceeds from stock options exercised | 0 | 18 |
| Proceeds from shares sold under employee stock purchase plan | 30 | 60 |
| Settlement of employee tax liabilities in connection with treasury stock transaction | 0 | 17 |
| Net cash used in financing activities | -1,234 | -5,602 |
| Effects of exchange rates on cash | 0 | 864 |
| Net cash provided by (used in) all activities | 1,849 | -582 |
| Cash and cash equivalents at beginning of period | 19,830 | - |
| Cash and cash equivalents at end of period | 21,097 | - |
INTEST CORP (INTT)
INTEST CORP (INTT)